These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 12510808)
1. Alendronate interacts with the inhibitory effect of 1,25(OH)2D3 on parathyroid hormone-related protein expression in human osteoblastic cells. Gómez-García L; Esbrit P; Carreño L; Sabando P; García-Flores M; Martinez ME J Bone Miner Res; 2003 Jan; 18(1):78-87. PubMed ID: 12510808 [TBL] [Abstract][Full Text] [Related]
2. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I. Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788 [TBL] [Abstract][Full Text] [Related]
3. Effects of 1,25(OH)2D3, EB1089, and analog V on PTHrP production, PTHrP mRNA expression and cell growth in SCC 2/88. Kunakornsawat S; Rosol TJ; Capen CC; Middleton RP; Hannah SS; Inpanbutr N Anticancer Res; 2001; 21(5):3355-63. PubMed ID: 11848494 [TBL] [Abstract][Full Text] [Related]
4. Age-related changes in parathyroid hormone-related protein and vascular endothelial growth factor in human osteoblastic cells. Martínez P; Esbrit P; Rodrigo A; Alvarez-Arroyo MV; Martínez ME Osteoporos Int; 2002 Nov; 13(11):874-81. PubMed ID: 12415434 [TBL] [Abstract][Full Text] [Related]
5. Thiazide diuretics affect osteocalcin production in human osteoblasts at the transcription level without affecting vitamin D3 receptors. Lajeunesse D; Delalandre A; Guggino SE J Bone Miner Res; 2000 May; 15(5):894-901. PubMed ID: 10804019 [TBL] [Abstract][Full Text] [Related]
6. 24R,25-dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells. Yamamoto T; Ozono K; Shima M; Yamaoka K; Okada S Exp Cell Res; 1998 Oct; 244(1):71-6. PubMed ID: 9770350 [TBL] [Abstract][Full Text] [Related]
7. Influence of aluminum on the regulation of PTH- and 1,25(OH)2D3-dependent pathways in the rat osteosarcoma cell line ROS 17/2.8. Lajeunesse D; Moreau R; Hobbs W; Qui W; Lafond J; Guggino SE J Bone Miner Res; 1998 Jun; 13(6):962-9. PubMed ID: 9626627 [TBL] [Abstract][Full Text] [Related]
8. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells. Miyahara T; Simoura T; Osahune N; Uchida Y; Sakuma T; Nemoto N; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Chiba H; Iba K; Sawada N Calcif Tissue Int; 2002 Jun; 70(6):488-95. PubMed ID: 12016462 [TBL] [Abstract][Full Text] [Related]
9. Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells. Inaba M; Terada M; Koyama H; Yoshida O; Ishimura E; Kawagishi T; Okuno Y; Nishizawa Y; Otani S; Morii H J Bone Miner Res; 1995 Jul; 10(7):1050-6. PubMed ID: 7484280 [TBL] [Abstract][Full Text] [Related]
10. Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes. Clemens TL; Tang H; Maeda S; Kesterson RA; Demayo F; Pike JW; Gundberg CM J Bone Miner Res; 1997 Oct; 12(10):1570-6. PubMed ID: 9333117 [TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor alpha decreases 1,25-dihydroxyvitamin D3 receptors in osteoblastic ROS 17/2.8 cells. Mayur N; Lewis S; Catherwood BD; Nanes MS J Bone Miner Res; 1993 Aug; 8(8):997-1003. PubMed ID: 8213262 [TBL] [Abstract][Full Text] [Related]
12. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes. Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745 [TBL] [Abstract][Full Text] [Related]
13. C-terminal parathyroid hormone-related protein inhibits proliferation and differentiation of human osteoblast-like cells. Martínez ME; García-Ocaña A; Sánchez M; Medina S; del Campo T; Valin A; Sanchez-Cabezudo MJ; Esbrit P J Bone Miner Res; 1997 May; 12(5):778-85. PubMed ID: 9144344 [TBL] [Abstract][Full Text] [Related]
14. 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies. Sterck JG; Klein-Nulend J; Burger EH; Lips P J Bone Miner Res; 1996 Mar; 11(3):367-76. PubMed ID: 8852947 [TBL] [Abstract][Full Text] [Related]
15. Effect of 1,25-dihydroxyvitamin D3 on the proliferation of osteoblastic MC3T3-E1 cells by modulating the release of local regulators from monocytes. Kanatani M; Sugimoto T; Fukase M; Chihara K Biochem Biophys Res Commun; 1993 Jan; 190(2):529-35. PubMed ID: 8427595 [TBL] [Abstract][Full Text] [Related]
16. Posttranscriptional regulation of osteocalcin mRNA in clonal osteoblast cells by 1,25-dihydroxyvitamin D3. Mosavin R; Mellon WS Arch Biochem Biophys; 1996 Aug; 332(1):142-52. PubMed ID: 8806719 [TBL] [Abstract][Full Text] [Related]
17. Expression and secretion of parathyroid hormone-related protein by human bone-derived cells in vitro: effects of glucocorticoids. Walsh CA; Birch MA; Fraser WD; Lawton R; Dorgan J; Walsh S; Sansom D; Beresford JN; Gallagher JA J Bone Miner Res; 1995 Jan; 10(1):17-25. PubMed ID: 7747625 [TBL] [Abstract][Full Text] [Related]
18. Hydrocortisone and deflazacort induce different effects on vitamin D receptor level increase produced by 1,25-dihydroxyvitamin D3 in rat osteoblast-like UMR-106 cells. Guerrero R; de la Piedra C; Teixeiro E; Bragado R; Traba ML J Rheumatol; 2004 Jan; 31(1):167-72. PubMed ID: 14705237 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological and biochemical evidence for the regulation of osteocalcin secretion by potassium channels in human osteoblast-like MG-63 cells. Moreau R; Aubin R; Lapointe JY; Lajeunesse D J Bone Miner Res; 1997 Dec; 12(12):1984-92. PubMed ID: 9421231 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of the receptor for parathyroid hormone (PTH) and PTH-related peptide by PTH in primary fetal rat osteoblasts. Jongen JW; Willemstein-van Hove EC; van der Meer JM; Bos MP; Jüppner H; Segre GV; Abou-Samra AB; Feyen JH; Herrmann-Erlee MP J Bone Miner Res; 1996 Sep; 11(9):1218-25. PubMed ID: 8864895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]